Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Xylem Inc (NYSE: XYL) closed at $140.67 in the last session, down -0.32% from day before closing price of $141.12. In other words, the price has decreased by -$0.32 from its previous closing price. On the day, 1.55 million shares were traded. XYL stock price reached its highest trading level at $141.63 during the session, while it also had its lowest trading level at $140.26.
Ratios:
We take a closer look at XYL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on September 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $165.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 04 ’25 when Harker Victoria D sold 1,700 shares for $148.14 per share. The transaction valued at 251,838 led to the insider holds 16,875 shares of the business.
VICTORIA HARKER bought 1,700 shares of XYL for $251,830 on Nov 04 ’25. On Oct 30 ’25, another insider, Toussaint Claudia S, who serves as the EVP, CPSO of the company, sold 10,421 shares for $152.64 each. As a result, the insider received 1,590,661 and left with 31,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 34248792064 and an Enterprise Value of 35384795136. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.19, and their Forward P/E ratio for the next fiscal year is 25.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.85 while its Price-to-Book (P/B) ratio in mrq is 3.06. Its current Enterprise Value per Revenue stands at 3.979 whereas that against EBITDA is 19.086.
Stock Price History:
The Beta on a monthly basis for XYL is 1.18, which has changed by 0.10755062 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, XYL has reached a high of $154.27, while it has fallen to a 52-week low of $100.47. The 50-Day Moving Average of the stock is -3.74%, while the 200-Day Moving Average is calculated to be 5.91%.
Shares Statistics:
According to the various share statistics, XYL traded on average about 1.28M shares per day over the past 3-months and 1775470 shares per day over the past 10 days. A total of 243.50M shares are outstanding, with a floating share count of 242.82M. Insiders hold about 0.26% of the company’s shares, while institutions hold 93.70% stake in the company. Shares short for XYL as of 1763078400 were 3194709 with a Short Ratio of 2.50, compared to 1760486400 on 2679414. Therefore, it implies a Short% of Shares Outstanding of 3194709 and a Short% of Float of 1.68.
Dividends & Splits
The forward annual dividend rate for XYL is 1.60, which was 1.56 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.011054422. The stock’s 5-year Average Dividend Yield is 1.13.
Earnings Estimates
Xylem Inc (XYL) is presently subject to a detailed evaluation by 19.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $1.16, with high estimates of $1.25 and low estimates of $1.05.
Analysts are recommending an EPS of between $5.1 and $4.85 for the fiscal current year, implying an average EPS of $5.05. EPS for the following year is $5.55, with 21.0 analysts recommending between $5.72 and $5.27.
Revenue Estimates
According to 19 analysts, . The current quarter’s revenue is expected to be $2.38B. It ranges from a high estimate of $2.43B to a low estimate of $2.32B. As of . The current estimate, Xylem Inc’s year-ago sales were $2.26BFor the next quarter, 19 analysts are estimating revenue of $2.18B. There is a high estimate of $2.23B for the next quarter, whereas the lowest estimate is $2.15B.
A total of 20 analysts have provided revenue estimates for XYL’s current fiscal year. The highest revenue estimate was $9.4B, while the lowest revenue estimate was $8.96B, resulting in an average revenue estimate of $9.03B. In the same quarter a year ago, actual revenue was $8.56BBased on 20 analysts’ estimates, the company’s revenue will be $9.36B in the next fiscal year. The high estimate is $9.49B and the low estimate is $9.12B.